Skip Navigation

Schizophrenia Bulletin 1998 24(2):231-248;
© 1998 by Oxford University Press and the Maryland Psychiatric Research Center (MPRC)
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Csernansky, J. G.
Right arrow Articles by Bardgett, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Csernansky, J. G.
Right arrow Articles by Bardgett, M. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press

Limbic-Cortical Neuronal Damage and the Pathophysiology of Schizophrenia

John G. Csernansky, M.D. and Mark E. Bardgett, Ph.D.
Gregory B. Couch Professor of Psychiatry and Neurobiology, Washington University School of Medicine, and Medical Director, Metropolitan St. Louis Psychiatric Center St. Louis, MO
Research Assistant Professor of Neurobiology in Psychiatry, Washington University School of Medicine St. Louis, MO

Reprint requests should be sent to Dr. J.G. Csernansky, Dept. of Psychiatry, Box 8134, Washington University School of Medicine, St. Louis, MO 63110

Neurobiological studies of patients with schizophrenia suggest that abnormalities of both anatomy and function occur in limbic-cortical structures. An anatomical circuit links the functioning of the ventral striatum (i.e., nucleus accumbens) with the hippocampus and other limbic-cortical structures where neurobiological abnormalities have been found. In animals, lesions of limbic-cortical neurons cause decreases in glutamatergic input to the nucleus accumbens and are also associated with decreases in presynaptic dopamine release, increases in the density of D2-like dopamine receptors, and insensitivity to the actions of dopamine antagonists such as haloperidol. These experiments suggest a plausible pathophysiology of schizophrenia, in that schizophrenic symptoms may be caused by an abnormal dopaminergic state brought about by a primary limbic-cortical lesion and deficits in glutamatergic inputs to the ventral striatum.

Keywords: Hippocampus / dopamine / antipsychotic drugs


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
H Afshar, H Roohafza, G Mousavi, S Golchin, N Toghianifar, M Sadeghi, and M Talaei
Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial
J Psychopharmacol, March 1, 2009; 23(2): 157 - 162.
[Abstract] [PDF]


Home page
Pharmacol. Rev.Home page
J. A. Lieberman, F. P. Bymaster, H. Y. Meltzer, A. Y. Deutch, G. E. Duncan, C. E. Marx, J. R. Aprille, D. S. Dwyer, X.-M. Li, S. P. Mahadik, et al.
Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection
Pharmacol. Rev., September 1, 2008; 60(3): 358 - 403.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
R. Lape and J. A. Dani
Complex Response to Afferent Excitatory Bursts by Nucleus Accumbens Medium Spiny Projection Neurons
J Neurophysiol, September 1, 2004; 92(3): 1276 - 1284.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
J. L. Sobell, M. J. Mikesell, and C. T. McMurray
Genetics and Etiopathophysiology of Schizophrenia
Mayo Clin. Proc., October 1, 2002; 77(10): 1068 - 1082.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.